Kiora Pharmaceuticals Inc.

KPRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.68

-$0.08 (-2.90%)

At close: Sep 21, 2026, 4:00 PM ET

$2.69

+$0.01 (+0.37%)

After-hours: Sep 21, 2026, 5:10 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $12.23M

Enterprise Value $-4.63M

Beta -0.39

Average Volume 33.03K

Shares Outstanding (Diluted) 6.18M

Shares Change YoY 54.87%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US49721T5074

Price Performance

Price Change 1M 1.1%

Price Change 3M 3.1%

Price Change 6M 31.4%

Price Change YTD 32.7%

Price Change 1Y 2.7%

Price Change 3Y -47.8%

Price Change 5Y -99.6%

1M CAGR (ann.) 7.8%

1Y CAGR (ann.) 4.2%

5Y CAGR (ann.) -65.8%

All-Time CAGR -55.4%

Valuation

PE Ratio -1.07

Forward PE N/A

PEG Ratio -0.05

Forward PEG 0.02

PS Ratio N/A

Forward PS 0.40

PB Ratio 0.70

P/FCF Ratio -1.38

P/Adj. FCF Ratio -1.33

P/OCF Ratio -1.94

EV/Sales N/A

EV/EBIT 0.45

EV/EBITDA 0.46

EV/FCF 0.54

Earnings Yield -93.3%

FCF Yield -72.5%

Adj. FCF Yield -75.4%

Financial Health

Net Cash $16.51M

Total Debt $333.02K

Cash & Short-Term Investments $16.84M

Total Assets $23.78M

Current Ratio 8.97

Quick Ratio 8.97

Debt / Equity Ratio 0.02

Debt / EBITDA -0.03

Debt / FCF -0.04

OCF / Debt -25.54

Interest Coverage 0.00

Altman Z-Score -8.75

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -4.0%

Returns

Return on Assets -46.2%

Return on Equity -63.4%

Return on Invested Capital -53.2%

Return on Capital Employed -59.9%

Return on Tangible Assets -50.6%

Historical Growth (CAGR)

Revenue CAGR 3Y -150.0%

Revenue CAGR 5Y 0.0%

Revenue CAGR 10Y 13.8%

EPS CAGR 3Y -164.4%

EPS CAGR 5Y 82.3%

EPS CAGR 10Y 41.9%

FCF CAGR 3Y -171.1%

FCF CAGR 5Y 9.5%

FCF CAGR 10Y 4.9%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y 50.5%

Revenue Growth Next 3Y N/A

Earnings Date Nov 5, 2026

EPS Estimate (next Q) -$0.38

EPS Growth Est (next Q) -3900.0%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-8.51M

Free Cash Flow $-8.61M

Adj. Free Cash Flow $-8.96M

FCF Per Share -$1.39

OCF Per Share -$1.38

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-41.98K

Operating Income $-10.61M

EBITDA $-10.14M

Net Income $-10.99M

EPS (Diluted) -$2.50

Revenue / Employee N/A

Profit / Employee $-845.13K

Employees 13